Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 12, 2026
BP and SHEL: Examining +37.7% and +35.3% Year-to-Date Gains Amid Energy Sector Strength

BP and SHEL: Examining +37.7% and +35.3% Year-to-Date Gains Amid Energy Sector Strength

Key Takeaways

  • Both BP and SHEL have posted strong year-to-date gains exceeding 35% amid favorable energy sector conditions in recent market activity.
  • BP has outperformed SHEL on a year-to-date basis with a return of approximately 37.7% compared to 35.3% for SHEL.
  • SHEL trades at a lower trailing price-to-earnings ratio of about 10.6 versus roughly 22.1 for BP, indicating differing valuation profiles.
  • SHEL maintains a larger market capitalization of approximately $277 billion compared to BP’s roughly $119 billion.
  • Both companies operate as integrated oil and gas majors with global exposure to upstream production, refining, and downstream activities.
  • Recent performance for both stocks reflects broader sector momentum driven by energy prices and operational updates in recent weeks.

Setting the Stage for Two Major Energy Players

Integrated energy companies BP and SHEL stand among the largest publicly traded names in the global oil and gas space. This comparison looks at their recent performance, business models, and market positioning to help investors and traders assess exposure to energy equities. The focus stays on measurable factors such as returns, valuation multiples, and sector dynamics, offering context for how these stocks have moved with shifting commodity markets and corporate plans. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in the industry.

BP’s Recent Performance and Operations

BP p.l.c. is an international integrated energy company involved in exploration, production, refining, and marketing of oil and gas, along with lower-carbon initiatives. In recent market activity, the stock has advanced to close near $46.10, delivering a year-to-date return of approximately 37.7% and a trailing twelve-month gain of about 40.6%. Performance in recent weeks has been supported by operational efficiency gains and sector tailwinds, with the share price trading within a 52-week range of $32.72 to $48.27. Market sentiment has reflected steady investor interest in the company’s upstream and refining segments. From what I see, the momentum aligns with broader energy trends.

SHEL’s Recent Performance and Operations

Shell plc is a global integrated energy and petrochemicals company involved in the exploration, production, refining, and marketing of oil, natural gas, and related products. The stock has recently closed near $96.77, posting a year-to-date return of approximately 35.3% and a trailing twelve-month gain of about 39.4%. In recent market activity, the shares have benefited from portfolio management actions and broader energy market conditions, trading within a 52-week range of $68.62 to $96.99. Sentiment has remained constructive amid ongoing operational updates and cash return initiatives. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to confirm the trend consistency.

Head-to-Head Comparison of Key Metrics

BP and SHEL share similar integrated business models spanning upstream exploration and production, downstream refining and marketing, and exposure to energy transition efforts. BP has delivered modestly higher year-to-date momentum, while SHEL offers a larger scale with a market capitalization nearly double that of BP. Valuation contrasts are notable: SHEL trades at a lower trailing price-to-earnings multiple, potentially appealing to value-oriented participants, whereas BP carries a higher multiple alongside a comparatively elevated dividend yield. Risk factors include commodity price volatility for both, with SHEL exhibiting a somewhat lower debt-to-equity profile in available data. Market sentiment has favored both amid sector strength, though relative positioning depends on investor preferences for growth momentum versus valuation support.

AI-Driven Observations on Relative Positioning

Based on observable factors such as trend consistency, relative returns, and positioning within the energy sector, Tickeron’s AI would currently assign a probabilistic edge to BP due to its stronger year-to-date performance and recent momentum signals. However, SHEL’s lower valuation multiple and larger scale could support more balanced consideration depending on specific strategy parameters and timeframe preferences. This assessment reflects data-driven observations rather than definitive outcomes. In my view, the edge remains modest and context-dependent.

Exploring AI Trading Bots for Portfolio Ideas

In my own research process, I often turn to Tickeron’s Trending AI Robots to review data-driven strategies across different market conditions. The platform highlights stronger-performing bots suited to current environments, covering various styles, timeframes, and ticker sets with metrics like win rates and drawdowns. This helps me cross-check ideas without replacing core analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BP, SHEL

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


BP in upward trend: price rose above 50-day moving average on September 30, 2026

BP moved above its 50-day moving average on September 30, 2026 date and that indicates a change from a downward trend to an upward trend. In 26 of 39 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 67%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on BP as a result. In 67 of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.

Following a +1.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where BP advanced for three days, in 213 of 357 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.

The Aroon Indicator entered an Uptrend today. In 148 of 279 cases where BP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 53%.

Bearish Trend Analysis

The 10-day RSI Indicator for BP moved out of overbought territory on September 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 26 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 70%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for BP turned negative on September 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 27 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 54%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 16 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 28, placing this stock better than average.

The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.958) is normal, around the industry mean (1.887). P/E Ratio (21.224) is within average values for comparable stocks, (16.521). Projected Growth (PEG Ratio) (0.058) is also within normal values, averaging (1.088). Dividend Yield (0.045) settles around the average of (0.035) among similar stocks. P/S Ratio (0.548) is also within normal values, averaging (3.764).

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. BP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 74 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are ExxonMobil Holdings Corporation (NYSE:XOM), Chevron Corp (NYSE:CVX), Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share) (NYSE:PBR), BP plc (NYSE:BP), Suncor Energy (NYSE:SU), YPF Sociedad Anonima (NYSE:YPF).

Industry description

Integrated oil companies are involved across nearly the entire oil value chain – from upstream operations like exploration and production, to downstream functions of refining and marketing. Exxon Mobil Corporation, Chevron Corporation and BP are major integrated oil companies. Their bottom lines’ response to crude oil prices could depend on the proportion of upstream vs. downstream businesses; for example, if a company has substantial downstream business, the adverse impact on their upstream business due to falling crude prices could be mitigated by benefits to its downstream business.

Market Cap

The average market capitalization across the Integrated Oil Industry is 124.33B. The market cap for tickers in the group ranges from 63.2K to 668.27B. XOM holds the highest valuation in this group at 668.27B. The lowest valued company is CRRDF at 63.2K.

High and low price notable news

The average weekly price growth across all stocks in the Integrated Oil Industry was 1%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 3%. PBR experienced the highest price growth at 17%, while TTE experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Integrated Oil Industry was 61%. For the same stocks of the Industry, the average monthly volume growth was 65% and the average quarterly volume growth was -26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 40
P/E Growth Rating: 50
Price Growth Rating: 47
SMR Rating: 55
Profit Risk Rating: 27
Seasonality Score: 14 (-100 ... +100)
View a ticker or compare two or three
BP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a producer of petroleum, natural gas and related products

Industry IntegratedOil

Industry
Integrated Oil
Address
1 St James's Square
Phone
+44 2074964000
Employees
93700
Web
https://www.bp.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
BP and SHEL: Examining +37.7% and +35.3% Year-to-Date Gains Amid Energy Sector Strength